{"mainPropery":{"diseaseId":1217,"diseaseName":"Retinal vasculopathy with cerebral leukodystrophy with systemic manifestations","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/1217/retinal-vasculopathy-with-cerebral-leukodystrophy-with-systemic-manifestations","synonyms":["Cerebroretinal vasculopathy, hereditary","CRV","Retinopathy, vascular, with cerebral and renal involvement and Raynaud and migraine phenomena","RVCL","Autosomal Dominant Retinal Vasculopathy with Cerebral Leukodystrophy","ADRVCL","Retinal vasculopathy and cerebral leukoencephalopathy","RVCL-S"],"synonyms-with-source":[{"name":"Cerebroretinal vasculopathy, hereditary"},{"name":"CRV"},{"name":"Retinopathy, vascular, with cerebral and renal involvement and Raynaud and migraine phenomena"},{"name":"RVCL","source":""},{"name":"Autosomal Dominant Retinal Vasculopathy with Cerebral Leukodystrophy","source":""},{"name":"ADRVCL","source":""},{"name":"Retinal vasculopathy and cerebral leukoencephalopathy","source":"OrphaData.Org"},{"name":"RVCL-S","source":""}],"identifiers":[{"identifierType":"OMIM","identifierId":"192315"},{"identifierType":"ORPHANET","identifierId":"247691"},{"identifierType":"UMLS","identifierId":"C1860518"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"},{"diseaseTypeId":26,"diseaseTypeName":"Kidney and Urinary Diseases","source":"Orphanet"},{"diseaseTypeId":15,"diseaseTypeName":"Musculoskeletal Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":2712,"resourceName":"Energy 4 a Cure Foundation","abbreviation":"","address1":"5000 Eldorado Parkway, Suite 150, #403","address2":"","address3":"","address4":"","address5":"","city":"Firsco","state":"TX","zip":"75033","country":"","phone":"281-825-2854","tty":"","tollFree":"","fax":"","email":"info@RVCLresearch.org","url":"http://www.rvclresearch.org/index.php","freeText":""},{"resourceID":3478,"resourceName":"European Association against Leukodystrophy","abbreviation":" ELA","address1":"2, rue Mi-les-Vignes","address2":"BP 61024 54521","address3":"Laxou Cedex","address4":"","address5":"","city":"","state":"","zip":"","country":"France","phone":"","tty":"","tollFree":"","fax":"","email":"http://ela-asso.com/en/contact-2/","url":"http://ela-asso.com/en/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/192315' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=retinal+vasculopathy+with+cerebral+leukodystrophy' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Retinal vasculopathy with cerebral leukodystrophy with systemic manifestations. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/gene/TREX1' target='_blank'>MedlinePlus Genetics</a> contains information on Retinal vasculopathy with cerebral leukodystrophy with systemic manifestations. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C1860518' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=247691' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/MONDO:0008641' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Retinal vasculopathy with cerebral leukodystrophy with systemic manifestations. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Retinal vasculopathy with cerebral leukodystrophy with systemic manifestations:<br />\r\n<a href='https://www.chop.edu/research/myelin-disorders-biorepository-project' target='_blank'>Myelin Disorders Bioregistry Project</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":7089,"questionText":"What is retinal vasculopathy with cerebral leukodystrophy and systemic manifestations?","answerText":"<strong>Retinal vasculopathy with cerebral leukodystrophy and systemic manifestations (RVCL-S)</strong>&nbsp;affects the small blood vessels in the central nervous system and other organs. Symptoms begin in adulthood and can include loss of vision, <a href=\"https://medlineplus.gov/raynaudsdisease.html\" target=\"_blank\">Raynaud's disease</a>, kidney and liver disease, and cognitive problems that get worse over time. Other symptoms may include migraines, gastrointestinal bleeding, and <a href=\"https://medlineplus.gov/hypothyroidism.html\" target=\"_blank\">hypothyroidism</a>. Death often occurs 10-15 years after the first symptoms appear. RVCL-S is caused by genetic variations&nbsp;in the <a href=\"https://medlineplus.gov/genetics/gene/trex1\" target=\"_blank\"><em>TREX1</em></a> gene, and is inherited in an autosomal dominant pattern. Diagnosis is based on the symptoms, clinical exam, imaging studies of the brain, and may be confirmed by the results of genetic testing. Treatment is focused on managing the symptoms.[15823][15824][15825]<br />\r\n<br />\r\nRVCL-S is considered to include the following three diseases which were previously thought to be separate conditions: <a target=\"_blank\">hereditary endotheliopathy, retinopathy, nephropathy, and stroke (HERNS)</a>; <a target=\"_blank\">cerebroretinal vasculopathy (CRV)</a>; and <a target=\"_blank\">hereditary vascular retinopathy (HVR)</a>.[15823]","dateModified":"2020-09-29T00:00:00"},"basicQuestions":[{"questionId":13674,"questionText":"What are the signs and symptoms of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S)?","answerText":"The following list includes the most common signs and symptoms in people with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S). These features may be different from person to person. Some people may have more symptoms than others and symptoms can range from mild to severe. This list does not include every symptom or feature that has been described in this condition.<br />\r\n<br />\r\nSymptoms of RVCL-S may include:[15823][15824][15825]<br />\r\n<ul>\r\n    <li>Vision problems due to retina damage (<a href=\"https://medlineplus.gov/retinaldisorders.html\" target=\"_blank\">retinopathy</a>)</li>\r\n    <li><a href=\"https://medlineplus.gov/raynaudsdisease.html\" target=\"_blank\">Raynaud's disease</a></li>\r\n    <li>Kidney disease</li>\r\n    <li>Liver disease</li>\r\n    <li>Gastrointestinal bleeding</li>\r\n    <li><a href=\"https://medlineplus.gov/highbloodpressure.html\" target=\"_blank\">Hypertension</a></li>\r\n    <li>Cognitive problems</li>\r\n    <li>Psychiatric disorders</li>\r\n</ul>\r\nThe first symptoms are Raynaud's disease and vision problems which may occur in the 20s. Vision problems tend to lead to blindness. Kidney and liver disease may occur in the 30s. Brain disease starts in the 40-50s. The symptoms of RVCL-S get worse over time, often leading to death in 10 to 15 years.[15824][15825]","dateModified":"2020-09-29T14:57:00","resourceClassificationName":"Symptoms","references":[{"referenceId":15823,"authors":"de Boer I, Pelzer N, Terwindt G","articleTitle":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Sept 19, 2020","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK546576","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15824,"authors":"Pelzer N, Hoogeveen ES, Haan J, Bunnik R, Poot CC, et al","articleTitle":"Systemic features of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a monogenic small vessel disease.","bookWebsiteJournalTitle":"J Intern Med","date":"Mar 2019","volume":"285(3)","pages":"317-332","url":"https://pubmed.ncbi.nlm.nih.gov/30411414","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15825,"authors":"Stam AH, Kothari PH, Shaikh A, Gschwendter A, Jen JC, et al","articleTitle":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations","bookWebsiteJournalTitle":"Brain","date":"Nov. 1, 2016","volume":"139(11)","pages":"2902-2922","url":"https://pubmed.ncbi.nlm.nih.gov/27604306","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13676,"questionText":"How is retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) inherited?","answerText":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is inherited in an autosomal dominant pattern.[15823] All individuals inherit two copies of each gene. Autosomal means the gene is found on one of the numbered chromosomes found in both sexes. Dominant means that only one altered copy of a gene is necessary to have the condition. The alteration can be inherited from either parent. Sometimes an autosomal dominant condition occurs because of a new genetic alteration (de novo) and there is no history of this condition in the family.<br />\r\n&nbsp;&nbsp;<br />\r\nEach child of an individual with an autosomal dominant condition has a 50% or 1 in 2 chance of inheriting the alteration and the condition. Typically, children who inherit a dominant alteration will have the condition, but they may be more or less severely affected than their parent. Sometimes a person may have a gene alteration for an autosomal dominant condition and show no signs or symptoms of the condition.<br />\r\n<br />","dateModified":"2020-09-29T15:11:00","resourceClassificationName":"Inheritance","references":[{"referenceId":15823,"authors":"de Boer I, Pelzer N, Terwindt G","articleTitle":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Sept 19, 2020","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK546576","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13677,"questionText":"How is retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) diagnosed?","answerText":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is diagnosed based on the symptoms, clinical examination, and imaging studies of the brain. The diagnosis can be confirmed based on the results of genetic testing.[15823][15825]","dateModified":"2020-09-29T15:17:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":15823,"authors":"de Boer I, Pelzer N, Terwindt G","articleTitle":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Sept 19, 2020","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK546576","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15825,"authors":"Stam AH, Kothari PH, Shaikh A, Gschwendter A, Jen JC, et al","articleTitle":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations","bookWebsiteJournalTitle":"Brain","date":"Nov. 1, 2016","volume":"139(11)","pages":"2902-2922","url":"https://pubmed.ncbi.nlm.nih.gov/27604306","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13678,"questionText":"How might retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) be treated?","answerText":"Treatment of&nbsp;retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is focused on managing the symptoms.<br />\r\n<br />\r\nSpecialists involved in the care of someone with RVCL-S may include:[15823]<br />\r\n<ul>\r\n    <li>Ophthalmologist</li>\r\n    <li>Neurologist</li>\r\n    <li>Nephrologist</li>\r\n    <li>Liver specialist</li>\r\n    <li>Endocrinologist</li>\r\n    <li>Hematologist</li>\r\n    <li>Rheumatologist</li>\r\n</ul>","dateModified":"2020-09-29T15:25:00","resourceClassificationName":"Treatment","references":[{"referenceId":15823,"authors":"de Boer I, Pelzer N, Terwindt G","articleTitle":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Sept 19, 2020","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK546576","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13675,"questionText":"What is the cause of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations?","answerText":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is caused by the <em><a href=\"https://ghr.nlm.nih.gov/gene/TREX1\" target=\"_blank\">TREX1</a></em> gene not working correctly.&nbsp;DNA changes known as pathogenic <a href=\"https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/variant\" target=\"_blank\">variants</a> are responsible for making genes work incorrectly or sometimes, not at all.[15823]","dateModified":"2020-09-29T15:04:00","resourceClassificationName":"Cause","references":[{"referenceId":15823,"authors":"de Boer I, Pelzer N, Terwindt G","articleTitle":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Sept 19, 2020","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK546576","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":13679,"questionText":"How many people have retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S)?","answerText":"There are about 200 reports of people with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) in the medical literature.[15826] It is not known exactly how many people have this condition.&nbsp;","dateModified":"2020-09-29T15:31:00","resourceClassificationName":"Statistics","references":[{"referenceId":15826,"authors":"Ford AL, Chin VW, Fellah S, Binkley MM, Bodin AM, et al","articleTitle":"Lesion evolution and neurodegeneration in RVCL-S: A monogenic microvasculopathy","bookWebsiteJournalTitle":"Neurology","date":"Sep 2020","volume":"4","pages":"10","url":"https://pubmed.ncbi.nlm.nih.gov/32887784","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[{"referenceId":15823,"authors":"de Boer I, Pelzer N, Terwindt G","articleTitle":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations","bookWebsiteJournalTitle":"GeneReviews","date":"Updated Sept 19, 2020","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK546576","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15824,"authors":"Pelzer N, Hoogeveen ES, Haan J, Bunnik R, Poot CC, et al","articleTitle":"Systemic features of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a monogenic small vessel disease.","bookWebsiteJournalTitle":"J Intern Med","date":"Mar 2019","volume":"285(3)","pages":"317-332","url":"https://pubmed.ncbi.nlm.nih.gov/30411414","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15825,"authors":"Stam AH, Kothari PH, Shaikh A, Gschwendter A, Jen JC, et al","articleTitle":"Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations","bookWebsiteJournalTitle":"Brain","date":"Nov. 1, 2016","volume":"139(11)","pages":"2902-2922","url":"https://pubmed.ncbi.nlm.nih.gov/27604306","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":15826,"authors":"Ford AL, Chin VW, Fellah S, Binkley MM, Bodin AM, et al","articleTitle":"Lesion evolution and neurodegeneration in RVCL-S: A monogenic microvasculopathy","bookWebsiteJournalTitle":"Neurology","date":"Sep 2020","volume":"4","pages":"10","url":"https://pubmed.ncbi.nlm.nih.gov/32887784","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[{"relatedDiseaseId":10534,"relatedDiseaseName":"Hereditary endotheliopathy, retinopathy, nephropathy, and stroke","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":10535,"relatedDiseaseName":"Hereditary vascular retinopathy","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13077,"phenoTypeName":"Focal white matter lesions","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5184,"phenoTypeName":"Leukodystrophy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14446,"phenoTypeName":"Abnormal retinal vascular morphology","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13858,"phenoTypeName":"Apraxia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6005,"phenoTypeName":"Behavioral abnormality","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8703,"phenoTypeName":"Dysarthria","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8728,"phenoTypeName":"Hemiparesis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8727,"phenoTypeName":"Mental deterioration","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13709,"phenoTypeName":"Migraine","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5641,"phenoTypeName":"Progressive visual loss","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10492,"phenoTypeName":"Retinopathy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9386,"phenoTypeName":"Stroke","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1889,"phenoTypeName":"Glomerulopathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14161,"phenoTypeName":"Hematuria","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5704,"phenoTypeName":"Micronodular cirrhosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10043,"phenoTypeName":"Nephropathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10031,"phenoTypeName":"Proteinuria","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13594,"phenoTypeName":"Sensory impairment","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14305,"phenoTypeName":"Abnormality of the periventricular white matter","percentRanges":"-"},{"phenoTypeId":6254,"phenoTypeName":"Adult onset","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":4478,"phenoTypeName":"Central nervous system degeneration","percentRanges":"-"},{"phenoTypeId":6020,"phenoTypeName":"Dementia","percentRanges":"-"},{"phenoTypeId":12040,"phenoTypeName":"Diminished ability to concentrate","percentRanges":"-"},{"phenoTypeId":6246,"phenoTypeName":"Elevated erythrocyte sedimentation rate","percentRanges":"-"},{"phenoTypeId":4319,"phenoTypeName":"Elevated hepatic transaminase","percentRanges":"-"},{"phenoTypeId":461,"phenoTypeName":"Limb pain","percentRanges":"-"},{"phenoTypeId":5171,"phenoTypeName":"Lower limb hyperreflexia","percentRanges":"-"},{"phenoTypeId":6825,"phenoTypeName":"Macular edema","percentRanges":"-"},{"phenoTypeId":5255,"phenoTypeName":"Progressive","percentRanges":"-"},{"phenoTypeId":37,"phenoTypeName":"Progressive forgetfulness","percentRanges":"-"},{"phenoTypeId":9431,"phenoTypeName":"Punctate vasculitis skin lesions","percentRanges":"-"},{"phenoTypeId":14615,"phenoTypeName":"Raynaud phenomenon","percentRanges":"-"},{"phenoTypeId":3050,"phenoTypeName":"Retinal exudate","percentRanges":"-"},{"phenoTypeId":9163,"phenoTypeName":"Retinal hemorrhage","percentRanges":"-"},{"phenoTypeId":8286,"phenoTypeName":"Telangiectasia","percentRanges":"-"},{"phenoTypeId":955,"phenoTypeName":"Vasculitis in the skin","percentRanges":"-"},{"phenoTypeId":5614,"phenoTypeName":"Visual impairment","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Retinal_vasculopathy_with_cerebral_leukodystrophy_with_systemic_manifestations"}